Treatment of premalignant skin lesions with topical imiquimod and photodynamic therapy in solid organ transplant patients - a randomized intra-individual trial with blinded efficacy assessment

Trial Profile

Treatment of premalignant skin lesions with topical imiquimod and photodynamic therapy in solid organ transplant patients - a randomized intra-individual trial with blinded efficacy assessment

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Jun 2015

At a glance

  • Drugs Imiquimod (Primary) ; Methyl aminolevulinate
  • Indications Actinic keratosis; Skin cancer; Viral infections; Warts
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 27 Jun 2015 Status changed from suspended to completed as reported by European Clinical Trials Database record.
    • 26 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top